BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 5474091)

  • 21. [Gout. Clinical aspects, pathogenesis, current treatment].
    Galmiche P
    Cah Med; 1971 Apr; 12(6):403-13. PubMed ID: 4934051
    [No Abstract]   [Full Text] [Related]  

  • 22. [Hyperuricemia and gout--treatment].
    Gröbner W; Walter-Sack I
    Dtsch Med Wochenschr; 2002 Feb; 127(5):210-3. PubMed ID: 11821994
    [No Abstract]   [Full Text] [Related]  

  • 23. Gout: 'a disease of plenty'.
    Rasaratnam I; Christophidis N
    Aust Fam Physician; 1995 May; 24(5):849-51, 855-6, 859-60. PubMed ID: 7794148
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Optimal management of chronic gout: attempting to render the (t)issues crystal-clear.
    Wong ML
    N Z Med J; 2005 Jun; 118(1217):U1533. PubMed ID: 15980907
    [No Abstract]   [Full Text] [Related]  

  • 25. [The internal therapy of patients with uric acid containing urinary calculi].
    Zöllner N
    Urologe; 1968; 7(1):46-50. PubMed ID: 5667553
    [No Abstract]   [Full Text] [Related]  

  • 26. [Observations on a random group of gout patients].
    Einaudi G; Marrazzi G; Pecchiura G
    Reumatismo; 1972; 24(1):21-9. PubMed ID: 4671625
    [No Abstract]   [Full Text] [Related]  

  • 27. [Early diagnosis and early treatment of gout].
    Mertz DP
    Hippokrates; 1968 Jan; 39(1):5-12. PubMed ID: 5667616
    [No Abstract]   [Full Text] [Related]  

  • 28. Understanding hyperuricemia: nursing implications.
    Johnson ES
    Nurs Clin North Am; 1972 Jun; 7(2):399-406. PubMed ID: 4482424
    [No Abstract]   [Full Text] [Related]  

  • 29. [Gout in the evolution of Von Gierke's disease].
    Benedetti A; Bucciante G; Cattano G; Nardini A
    Minerva Med; 1969 May; 60(38):1849-59. PubMed ID: 5255205
    [No Abstract]   [Full Text] [Related]  

  • 30. [Diagnosis and treatment of gout: not always simple].
    van Vugt RM; Jacobs JW; Bijlsma JW
    Ned Tijdschr Geneeskd; 1996 Jan; 140(4):177-9. PubMed ID: 8618639
    [No Abstract]   [Full Text] [Related]  

  • 31. [Uricoeliminating or urico-inhibiting agents? Reasons for a choice].
    Cottin S; Prost A
    Sem Hop; 1972 May; 48(24):1739-42. PubMed ID: 4340887
    [No Abstract]   [Full Text] [Related]  

  • 32. [Drug therapy of hyperuricemia].
    Gröbner W
    Verh Dtsch Ges Inn Med; 1986; 92():492-7. PubMed ID: 3811551
    [No Abstract]   [Full Text] [Related]  

  • 33. [Summary of the Dutch College of General Practitioners' "Gout" Standard].
    Romeijnders AC; Gorter KJ
    Ned Tijdschr Geneeskd; 2002 Feb; 146(7):309-13. PubMed ID: 11876034
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of gout with the combination of xanthine oxidase inhibitors and uricosuric agents].
    Delbarre F; Saporta L; de Géry A; Jabre E
    Rev Rhum Mal Osteoartic; 1970; 37(6):443-50. PubMed ID: 5453852
    [No Abstract]   [Full Text] [Related]  

  • 35. [Gout].
    Gröbner W; Zöllner N
    Z Rheumatol; 2004 Feb; 63(1):2-9. PubMed ID: 14991273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP
    Munch Med Wochenschr; 1969 Feb; 111(9):491-5. PubMed ID: 5818966
    [No Abstract]   [Full Text] [Related]  

  • 37. Gout.
    Scott JT
    J R Coll Gen Pract; 1969 Nov; 18(88 Suppl 3):11-4. PubMed ID: 5351010
    [No Abstract]   [Full Text] [Related]  

  • 38. [Current status of gout (physiopathological, morphological, clinical and therapeutic aspects)].
    Mosora M; Boloşiu H
    Med Interna (Bucur); 1972 Sep; 24(9):1069-77. PubMed ID: 4651385
    [No Abstract]   [Full Text] [Related]  

  • 39. The treatment of hyperuricemia in gout.
    Rastegar A; Thier SO
    Ration Drug Ther; 1974 Mar; 8(3):1-4. PubMed ID: 4820829
    [No Abstract]   [Full Text] [Related]  

  • 40. [Kidney involvement in gout].
    Stein G
    Beitr Rheumatol; 1972; 18():61-7. PubMed ID: 4649120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.